[Management of dyslipidemia in diabetic CKD patients].
Diabetic nephropathy is a frequent complication in type 2 diabetic. Patients with diabetic nephropathy have a characteristic dyslipidemia profile associated increased concentrations of triglycerides, reduced levels of HDL cholesterol, and qualitative abnormalities of LDL. The dyslipidemia management in patients with diabetic nephropathy not yet in dialysis includes diet, insulin sensitizers (glitazones, metformin?), and hypolipemic agents, with statins as a first choice.